| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A vaccine capable of eliciting an antitumor response for prostate tumors; prostate-specific antigen, prostate-specific membrane antigen or prostate acid phosphatase gene cloning and expression for use as a recombinant vaccine or in genetic immunization
|
|
|
1995
|
13 |
11 |
p. 1040-
1 p.
|
article
|
| 2 |
Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies
|
Jones, David H.
|
|
1995
|
13 |
11 |
p. 991-999
9 p.
|
article
|
| 3 |
Filamentous bacteriophage engineered to display T- and B-cell epitopes and/or a peptide eliciting HIV virus neutralizing antibodies; phage fd phage display of e.g. foot-and-mouth-disease virus epitope in major coat protein for recombinant vaccine construction
|
|
|
1995
|
13 |
11 |
p. 1040-
1 p.
|
article
|
| 4 |
Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein
|
Langeveld, Jan P.M.
|
|
1995
|
13 |
11 |
p. 1033-1037
5 p.
|
article
|
| 5 |
Heat stabilized, infectious poliovirus
|
Ofori-Anyinam, Opokua
|
|
1995
|
13 |
11 |
p. 983-986
4 p.
|
article
|
| 6 |
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
|
Moldoveanu, Z.
|
|
1995
|
13 |
11 |
p. 1006-1012
7 p.
|
article
|
| 7 |
Human melanoma antigen MAGE-1 peptide; tumor-associated antigen gene cloning and expression for use in antitumor recombinant vaccine production
|
|
|
1995
|
13 |
11 |
p. 1040-
1 p.
|
article
|
| 8 |
Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins
|
Moldoveanu, Zina
|
|
1995
|
13 |
11 |
p. 1013-1022
10 p.
|
article
|
| 9 |
Immunity to St. Louis encephalitis virus by sequential immunization with recombinant vaccinia and baculovirus derived PrM/E proteins
|
Venugopal, K.
|
|
1995
|
13 |
11 |
p. 1000-1005
6 p.
|
article
|
| 10 |
Modulation of self-proteins by insertion of foreign T-lymphocyte epitope(s); autovaccine development for use against e.g. cancer, allergies and chronic inflammatory diseases
|
|
|
1995
|
13 |
11 |
p. 1040-
1 p.
|
article
|
| 11 |
New antigenic tick carboxypeptidase and corresponding DNA; useful in recombinant vaccine
|
|
|
1995
|
13 |
11 |
p. 1040-
1 p.
|
article
|
| 12 |
Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age
|
Arístegui, J.
|
|
1995
|
13 |
11 |
p. 973-977
5 p.
|
article
|
| 13 |
Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection
|
Su, Hua
|
|
1995
|
13 |
11 |
p. 1023-1032
10 p.
|
article
|
| 14 |
Randomized comparison of 5 and 10 μg doses of two recombinant hepatitis B vaccines
|
Bryan, Joe P.
|
|
1995
|
13 |
11 |
p. 978-982
5 p.
|
article
|
| 15 |
Reappraisal of existing methods for potency testing of vaccines against tetanus and diphtheria
|
Gupta, Rajesh K.
|
|
1995
|
13 |
11 |
p. 965-966
2 p.
|
article
|
| 16 |
Report of a meeting on “Vaccines; new technologies and applications”
|
Spier, R.E.
|
|
1995
|
13 |
11 |
p. 1038-1039
2 p.
|
article
|
| 17 |
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax®) in healthy adolescents and adults
|
Kuter, Barbara J.
|
|
1995
|
13 |
11 |
p. 967-972
6 p.
|
article
|
| 18 |
The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children
|
Nayir, Ahmet
|
|
1995
|
13 |
11 |
p. 987-990
4 p.
|
article
|
Journal description